Supreme Court Rebuffs Solicitor General, Takes LabCorp Case

Law360, New York (October 31, 2005, 12:00 AM EST) -- Despite a recommendation from the Bush administration urging it not to hear the case, the U.S. Supreme Court has decided to consider a patent infringement suit covering technology that predicts heart attacks, strokes, and dementia.

The suit was filed by Competitive Technologies licensee Metabolite Inc. against Laboratory Corporation, alleging LabCorp infringed a CTT patent for homocysteine assays instrumental in predicting the medical conditions.

Last month, the U.S. Solicitor General recommended to the U.S. Supreme Court that LabCorp’s appeal be denied.

LabCorp filed the petition for a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.